Ocular Finding in Alopecia Areata
Keywords
Abstract
Description
Alopecia areata is now considered a systemic autoimmune disease that may have other serious comorbidities, such as cardiovascular and ocular. However, the results of studies of ocular findings in AA are controversial.
Several ocular alterations have been previously reported in patients with AA ranging from minor punctate opacities to cataract. However, there are contrasting opinions on the significance of these lenticular changes. In addition, Horner syndrome, pupil ectopia, iris atrophy, fundus changes , bilateral keratoconus, iris changes and retinal changes have been reported in AA.
Dermoscopy is a noninvasive, diagnostic tool which visualizes subtle patterns of skin lesions not normally visible to the unaided eye. Characteristic dermoscopic finding of AA included black dots , tapering hair corresponding to " exclamation mark hairs " , broken hairs , yellow dots , and clustered short vellus hairs ( shorter than 10 mm).
Since ocular affection can be a profound morbidity factor in patients with AA, we will search deeply in this study about this correlation in order to conclude the value of ocular screening in each and every patient with AA.
Dates
Last Verified: | 04/30/2017 |
First Submitted: | 05/14/2017 |
Estimated Enrollment Submitted: | 05/14/2017 |
First Posted: | 05/15/2017 |
Last Update Submitted: | 05/14/2017 |
Last Update Posted: | 05/15/2017 |
Actual Study Start Date: | 06/30/2017 |
Estimated Primary Completion Date: | 06/30/2019 |
Estimated Study Completion Date: | 12/31/2019 |
Condition or disease
Phase
Eligibility Criteria
Sexes Eligible for Study | All |
Sampling method | Non-Probability Sample |
Accepts Healthy Volunteers | Yes |
Criteria | Inclusion Criteria: - patients of alopecia areata will be recruited from the Dermatology Outpatients' Clinic, Assiut University Hospitals, Assiut, Egypt. Exclusion Criteria: 1. Patients with documented eye disease. 2. Patients with any systemic illness. 3. Patients who received any systemic treatment with possible ocular implications in the last three months. |
Outcome
Primary Outcome Measures
1. the number of patient with occular affection in alopecia areata [2 years]
Secondary Outcome Measures
1. correlate dermoscopic finding with disease severity and ocular finding [2 years]